Select the Abstracts by Number

Click    to view the poster

617   Fatal Hepatotoxicity Associated with Combination Hydroxyurea and Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Cases From the FDA Adverse Event Reporting System (AERS).

618   Hepatotoxicity Associated with NNRTI Use: Role of Drugs and Chronic Viral Hepatitis.

619   Risk of HAART-Induced Hyperglycemia in HIV/HCV-Coinfected Patients.

620   Incidence of Pancreatitis in HIV-Infected Patients on Nucleoside RTIs.

621   Epidemiological Risk Factors and Immunological Mechanisms of Hypersensitivity Reactions to Abacavir.

622   Comparison of Symptoms of Influenza A Infection with Abacavir-Associated Hypersensitivity Reaction.

623   Iron Overload in HIV-Infected Drug Users with HAART Treatment.

624   Incidence and Outcome of Hyperlactatemia Associated with Clinical Manifestations in HIV-Infected Adults Receiving NRTI-Containing Regimens.

625   Hyperlactatemia in HIV-Infected Patients: The Role of NRTI Treatment.

625B   Mitochondrial and Mitochondrial-Like Symptoms in Children Born to HIV-Infected Mothers. Exhaustive Evaluation in a Large Prospective Cohort.